Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Manzini

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2006
Genetically modified pigs produced with a nonviral episomal vectorStefano Manzini, Alessia Vargiolu, Isa M Stehle, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 19, 2022
Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of HyperlipidemiaMarco Busnelli, Stefano Manzini, Alice Colombo, et al.
Plos One|November 22, 2013
Diet induced mild hypercholesterolemia in pigs: local and systemic inflammation, effects on vascular injury - rescue by high-dose statin treatmentMarco Busnelli, Stefano Manzini, Alberto Froio, et al.
BMC Medical Genetics|October 21, 2006
Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patientsAngela Bentivegna, Donatella Milani, Cristina Gervasini, et al.
Plos One|May 21, 2014
A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient miceCinzia Parolini, Rita Vik, Marco Busnelli, et al.
Plos One|December 11, 2013
An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoe(-/-) miceRita Vik, Marco Busnelli, Cinzia Parolini, et al.
Disease Models & Mechanisms|February 22, 2023
Autism-linked NLGN3 is a key regulator of gonadotropin-releasing hormone deficiencyRoberto Oleari, Antonella Lettieri, Stefano Manzini, et al.
Cardiovascular Research|November 6, 2019
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunctionNicoletta Piroddi, Paola Pesce, Beatrice Scellini, et al.
Molecular Cancer Therapeutics|June 23, 2019
MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid TumorsGiuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2006
Genetically modified pigs produced with a nonviral episomal vectorStefano Manzini, Alessia Vargiolu, Isa M Stehle, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 19, 2022
Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of HyperlipidemiaMarco Busnelli, Stefano Manzini, Alice Colombo, et al.
Plos One|November 22, 2013
Diet induced mild hypercholesterolemia in pigs: local and systemic inflammation, effects on vascular injury - rescue by high-dose statin treatmentMarco Busnelli, Stefano Manzini, Alberto Froio, et al.
BMC Medical Genetics|October 21, 2006
Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patientsAngela Bentivegna, Donatella Milani, Cristina Gervasini, et al.
Plos One|May 21, 2014
A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient miceCinzia Parolini, Rita Vik, Marco Busnelli, et al.
Plos One|December 11, 2013
An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoe(-/-) miceRita Vik, Marco Busnelli, Cinzia Parolini, et al.
Disease Models & Mechanisms|February 22, 2023
Autism-linked NLGN3 is a key regulator of gonadotropin-releasing hormone deficiencyRoberto Oleari, Antonella Lettieri, Stefano Manzini, et al.
Cardiovascular Research|November 6, 2019
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunctionNicoletta Piroddi, Paola Pesce, Beatrice Scellini, et al.
Molecular Cancer Therapeutics|June 23, 2019
MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid TumorsGiuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, et al.
Pageof 5